Synthetic Biology Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032

Description

Persistence Market Research has recently released a comprehensive report on the worldwide market for synthetic biology. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

Synthetic Biology Market Size (2024E): USD 20.9 Bn
Projected Market Value (2032F): USD 210.7 Bn
Global Market Growth Rate (CAGR 2024 to 2032): 29.3%

Synthetic Biology Market - Report Scope:

Synthetic biology involves the design and construction of new biological parts, devices, and systems or the re-design of existing, natural biological systems for useful purposes. This interdisciplinary field combines elements of biology, engineering, genetics, chemistry, and computer science to address complex challenges in various sectors, including healthcare, agriculture, and environmental management. The synthetic biology market encompasses a wide range of applications such as biofuels, bioplastics, pharmaceuticals, and genetically modified organisms (GMOs).

Market Growth Drivers:

The global synthetic biology market is propelled by several key factors, including the increasing demand for sustainable and eco-friendly solutions across industries. Advances in genetic engineering technologies, such as CRISPR-Cas9, have significantly accelerated the development of synthetic biology applications, making it easier and more cost-effective to engineer biological systems. The rising prevalence of chronic diseases and the need for innovative therapeutic solutions also drive market growth, as synthetic biology offers new pathways for drug development and personalized medicine. Additionally, government initiatives and funding support for synthetic biology research and development further stimulate market expansion.

Market Restraints:

Despite promising growth prospects, the synthetic biology market faces challenges related to ethical concerns, biosafety, and regulatory frameworks. The potential risks associated with the release of genetically engineered organisms into the environment and the ethical implications of genetic modifications pose significant barriers to market growth. Regulatory compliance and the establishment of standardized protocols for synthetic biology research and applications remain critical challenges that need to be addressed to ensure safe and responsible development in this field. Moreover, high research and development costs and technical complexities in synthetic biology can hinder market penetration, particularly in developing regions with limited resources.

Market Opportunities:

The synthetic biology market presents significant growth opportunities driven by technological innovations, increasing industrial applications, and evolving healthcare needs. The development of novel synthetic biology tools and platforms, such as synthetic gene circuits and metabolic engineering, expands the scope of applications and enhances the efficiency of synthetic biology processes. The integration of artificial intelligence and machine learning in synthetic biology research accelerates the discovery and optimization of new biological pathways and systems. Strategic partnerships, investment in research and development, and the commercialization of synthetic biology products and services are essential to capitalize on emerging opportunities and sustain market leadership in this dynamic field.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the synthetic biology market globally?
Which applications are driving synthetic biology adoption across different industries?
How are technological advancements reshaping the competitive landscape of the synthetic biology market?
Who are the key players contributing to the synthetic biology market, and what strategies are they employing to maintain market relevance?
What are the emerging trends and future prospects in the global synthetic biology market?

Competitive Intelligence and Business Strategy:

Leading players in the global synthetic biology market, including Thermo Fisher Scientific Inc., Merck KGaA, and GenScript Biotech Corporation, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced synthetic biology solutions, including synthetic DNA, gene synthesis services, and custom-engineered organisms, catering to diverse industry needs and research requirements. Collaborations with academic institutions, biotechnology firms, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on ethical practices, biosafety, and regulatory compliance fosters market growth and enhances public trust in synthetic biology applications.

Key Companies Profiled:

Bota Biosciences
Codexis, Inc.
Creative Biogene
Creative Enzymes
EnBiotix, Inc.
Eurofins Scientific
Illumina
Merck
New England Biolabs
Novozymes
Pareto Biotechnologies, Inc.
Scarab Genomics
Synthego
Synthetic Genomics
Thermo Fisher

Market Segments Covered in Synthetic Biology Market Analysis

By Application

Healthcare
Non-Healthcare

By Product Type

Oligonucleotide/Oligo pools and Synthetic DNA
Enzymes
Cloning Technologies Kits
Xeno-nucleic Acids
Chassis Organism

By Technology

NGS
PCR
Genome Editing
Bioprocessing Technology
Other Technologies

By End-use

Biotechnology & Pharmaceutical Companies
Academic & Government Research Institutes
Other End-uses

By Region type

North America
Latin America
Europe
APAC
MEA

Product Code: PMRREP33250

1. Executive Summary

1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage
2.2. Market Definition

3. Market Risks and Trends Assessment

3.1. Risk Assessment
- 3.1.1. COVID-19 Crisis and Impact on Synthetic Biology
- 3.1.2. COVID-19 Impact Benchmark with Previous Crisis
- 3.1.3. Impact on Market Value (US$ Bn)
- 3.1.4. Assessment by Key Countries
- 3.1.5. Assessment by Key Market Segments
- 3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends

4. Market Background

4.1. Synthetic Biology Market, by Key Countries
4.2. Synthetic Biology Market Opportunity Assessment (US$ Bn)
- 4.2.1. Total Available Market
- 4.2.2. Serviceable Addressable Market
- 4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
- 4.3.1. Demand in optimistic Scenario
- 4.3.2. Demand in Likely Scenario
- 4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
- 4.4.1. Investment in Established Markets
  - 4.4.1.1. In Short Term
  - 4.4.1.2. In Long Term
- 4.4.2. Investment in Emerging Markets
  - 4.4.2.1. In Short Term
  - 4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
- 4.5.1. Top Companies Historical Growth
- 4.5.2. Growth in Automation, By Country
- 4.5.3. Synthetic Biology Adoption Rate, By Country
4.6. Market Dynamics
- 4.6.1. Market Driving Factors and Impact Assessment
- 4.6.2. Prominent Market Challenges and Impact Assessment
- 4.6.3. Synthetic Biology Market Opportunities
- 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors

5.1. Manufacturers' Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking

6. Global Synthetic Biology Market Demand Analysis 2019-2023 and Forecast, 2024-2032

6.1. Historical Market Analysis, 2019-2023
6.2. Current and Future Market Projections, 2024-2032
6.3. Y-o-Y Growth Trend Analysis

7. Global Synthetic Biology Market Value Analysis 2019-2023 and Forecast, 2024-2032

7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
7.2. Current and Future Market Value (US$ Bn) Projections, 2024-2032
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis

8. Global Synthetic Biology Market Analysis 2019-2023 and Forecast 2024-2032, By Application

8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Application, 2024-2032
- 8.3.1. Healthcare
  - 8.3.1.1. Clinical
  - 8.3.1.2. Non-Clinical /Research
- 8.3.2. Non-Healthcare
  - 8.3.2.1. Biotech Crops
  - 8.3.2.2. Speciality Chemicals
  - 8.3.2.3. Bio-Fuels
8.4. Market Attractiveness Analysis By Application

9. Global Synthetic Biology Market Analysis 2019-2023 and Forecast 2024-2032, By Product Type

9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Product Type, 2024-2032
- 9.3.1. Oligonucleotide/Oligo pools and Synthetic DNA
- 9.3.2. Enzymes
- 9.3.3. Cloning Technologies Kits
- 9.3.4. Xeno-nucleic Acids
- 9.3.5. Chassis Organism
9.4. Market Attractiveness Analysis By Product Type

10. Global Synthetic Biology Market Analysis 2019-2023 and Forecast 2024-2032, By Technology

10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Bn) Analysis By Technology, 2019-2023
10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Technology, 2024-2032
- 10.3.1. NGS
- 10.3.2. PCR
- 10.3.3. Genome Editing
- 10.3.4. Other Technologies
10.4. Market Attractiveness Analysis By Technology

11. Global Synthetic Biology Market Analysis 2019-2023 and Forecast 2024-2032, By End-use

11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Bn) Analysis By End-use, 2019-2023
11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End-use, 2024-2032
- 11.3.1. Biotechnology & Pharmaceutical Companies
- 11.3.2. Academic & Government Research Institutes
- 11.3.3. Other End-uses
11.4. Market Attractiveness Analysis By End-use

12. Global Synthetic Biology Market Analysis 2019-2023 and Forecast 2024-2032, By Region

12.1. Introduction
12.2. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
12.3. Current Market Size (US$ Bn) & Analysis and Forecast By Region, 2024-2032
- 12.3.1. North America
- 12.3.2. Latin America
- 12.3.3. Europe
- 12.3.4. Asia Pacific
- 12.3.5. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis By Region

13. North America Synthetic Biology Market Analysis 2019-2023 and Forecast 2024-2032

13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
13.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2024-2032
- 13.4.1. By Country
  - 13.4.1.1. U.S.
  - 13.4.1.2. Canada
  - 13.4.1.3. Rest of North America
- 13.4.2. By Application
- 13.4.3. By Product Type
- 13.4.4. By Technology
- 13.4.5. By End-use
13.5. Market Attractiveness Analysis
- 13.5.1. By Country
- 13.5.2. By Application
- 13.5.3. By Product Type
- 13.5.4. By Technology
- 13.5.5. By End-use

14. Latin America Synthetic Biology Market Analysis 2019-2023 and Forecast 2024-2032

14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
14.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2024-2032
- 14.4.1. By Country
  - 14.4.1.1. Brazil
  - 14.4.1.2. Mexico
  - 14.4.1.3. Rest of Latin America
- 14.4.2. By Application
- 14.4.3. By Product Type
- 14.4.4. By Technology
- 14.4.5. By End-use
14.5. Market Attractiveness Analysis
- 14.5.1. By Country
- 14.5.2. By Application
- 14.5.3. By Product Type
- 14.5.4. By Technology
- 14.5.5. By End-use

15. Europe Synthetic Biology Market Analysis 2019-2023 and Forecast 2024-2032

15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
15.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2024-2032
- 15.4.1. By Country
  - 15.4.1.1. Germany
  - 15.4.1.2. France
  - 15.4.1.3. U.K.
  - 15.4.1.4. Italy
  - 15.4.1.5. Benelux
  - 15.4.1.6. Nordic Countries
  - 15.4.1.7. Rest of Europe
- 15.4.2. By Application
- 15.4.3. By Product Type
- 15.4.4. By Technology
- 15.4.5. By End-use
15.5. Market Attractiveness Analysis
- 15.5.1. By Country
- 15.5.2. By Application
- 15.5.3. By Product Type
- 15.5.4. By Technology
- 15.5.5. By End-use

16. Asia Pacific Synthetic Biology Market Analysis 2019-2023 and Forecast 2024-2032

16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
16.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2024-2032
- 16.4.1. By Country
  - 16.4.1.1. China
  - 16.4.1.2. Japan
  - 16.4.1.3. South Korea
  - 16.4.1.4. Rest of Asia Pacific
- 16.4.2. By Application
- 16.4.3. By Product Type
- 16.4.4. By Technology
- 16.4.5. By End-use
16.5. Market Attractiveness Analysis
- 16.5.1. By Country
- 16.5.2. By Application
- 16.5.3. By Product Type
- 16.5.4. By Technology
- 16.5.5. By End-use

17. Middle East and Africa Synthetic Biology Market Analysis 2019-2023 and Forecast 2024-2032

17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
17.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2024-2032
- 17.4.1. By Country
  - 17.4.1.1. GCC Countries
  - 17.4.1.2. South Africa
  - 17.4.1.3. Turkey
  - 17.4.1.4. Rest of Middle East and Africa
- 17.4.2. By Application
- 17.4.3. By Product Type
- 17.4.4. By Technology
- 17.4.5. By End-use
17.5. Market Attractiveness Analysis
- 17.5.1. By Country
- 17.5.2. By Application
- 17.5.3. By Product Type
- 17.5.4. By Technology
- 17.5.5. By End-use

18. Key Countries Synthetic Biology Market Analysis 2019-2023 and Forecast 2024-2032

18.1. Introduction
- 18.1.1. Market Value Proportion Analysis, By Key Countries
- 18.1.2. Global Vs. Country Growth Comparison
18.2. US Synthetic Biology Market Analysis
- 18.2.1. Value Proportion Analysis by Market Taxonomy
- 18.2.2. Value Analysis and Forecast by Market Taxonomy, 2019-2032
  - 18.2.2.1. By Application
  - 18.2.2.2. By Product Type
  - 18.2.2.3. By Technology
  - 18.2.2.4. By End-use
18.3. Canada Synthetic Biology Market Analysis
- 18.3.1. Value Proportion Analysis by Market Taxonomy
- 18.3.2. Value Analysis and Forecast by Market Taxonomy, 2019-2032
  - 18.3.2.1. By Application
  - 18.3.2.2. By Product Type
  - 18.3.2.3. By Technology
  - 18.3.2.4. By End-use
18.4. Mexico Synthetic Biology Market Analysis
- 18.4.1. Value Proportion Analysis by Market Taxonomy
- 18.4.2. Value Analysis and Forecast by Market Taxonomy, 2019-2032
  - 18.4.2.1. By Application
  - 18.4.2.2. By Product Type
  - 18.4.2.3. By Technology
  - 18.4.2.4. By End-use
18.5. Brazil Synthetic Biology Market Analysis
- 18.5.1. Value Proportion Analysis by Market Taxonomy
- 18.5.2. Value Analysis and Forecast by Market Taxonomy, 2019-2032
  - 18.5.2.1. By Application
  - 18.5.2.2. By Product Type
  - 18.5.2.3. By Technology
  - 18.5.2.4. By End-use
18.6. Germany Synthetic Biology Market Analysis
- 18.6.1. Value Proportion Analysis by Market Taxonomy
- 18.6.2. Value Analysis and Forecast by Market Taxonomy, 2019-2032
  - 18.6.2.1. By Application
  - 18.6.2.2. By Product Type
  - 18.6.2.3. By Technology
  - 18.6.2.4. By End-use
18.7. France Synthetic Biology Market Analysis
- 18.7.1. Value Proportion Analysis by Market Taxonomy
- 18.7.2. Value Analysis and Forecast by Market Taxonomy, 2019-2032
  - 18.7.2.1. By Application
  - 18.7.2.2. By Product Type
  - 18.7.2.3. By Technology
  - 18.7.2.4. By End-use
18.8. Italy Synthetic Biology Market Analysis
- 18.8.1. Value Proportion Analysis by Market Taxonomy
- 18.8.2. Value Analysis and Forecast by Market Taxonomy, 2019-2032
  - 18.8.2.1. By Application
  - 18.8.2.2. By Product Type
  - 18.8.2.3. By Technology
  - 18.8.2.4. By End-use
18.9. BENELUX Synthetic Biology Market Analysis
- 18.9.1. Value Proportion Analysis by Market Taxonomy
- 18.9.2. Value Analysis and Forecast by Market Taxonomy, 2019-2032
  - 18.9.2.1. By Application
  - 18.9.2.2. By Product Type
  - 18.9.2.3. By Technology
  - 18.9.2.4. By End-use
18.10. UK Synthetic Biology Market Analysis
- 18.10.1. Value Proportion Analysis by Market Taxonomy
- 18.10.2. Value Analysis and Forecast by Market Taxonomy, 2019-2032
  - 18.10.2.1. By Application
  - 18.10.2.2. By Product Type
  - 18.10.2.3. By Technology
  - 18.10.2.4. By End-use
18.11. Nordic Countries Synthetic Biology Market Analysis
- 18.11.1. Value Proportion Analysis by Market Taxonomy
- 18.11.2. Value Analysis and Forecast by Market Taxonomy, 2019-2032
  - 18.11.2.1. By Application
  - 18.11.2.2. By Product Type
  - 18.11.2.3. By Technology
  - 18.11.2.4. By End-use
18.12. China Synthetic Biology Market Analysis
- 18.12.1. Value Proportion Analysis by Market Taxonomy
- 18.12.2. Value Analysis and Forecast by Market Taxonomy, 2019-2032
  - 18.12.2.1. By Application
  - 18.12.2.2. By Product Type
  - 18.12.2.3. By Technology
  - 18.12.2.4. By End-use
18.13. Japan Synthetic Biology Market Analysis
- 18.13.1. Value Proportion Analysis by Market Taxonomy
- 18.13.2. Value Analysis and Forecast by Market Taxonomy, 2019-2032
  - 18.13.2.1. By Application
  - 18.13.2.2. By Product Type
  - 18.13.2.3. By Technology
  - 18.13.2.4. By End-use
18.14. South Korea Synthetic Biology Market Analysis
- 18.14.1. Value Proportion Analysis by Market Taxonomy
- 18.14.2. Value Analysis and Forecast by Market Taxonomy, 2019-2032
  - 18.14.2.1. By Application
  - 18.14.2.2. By Product Type
  - 18.14.2.3. By Technology
  - 18.14.2.4. By End-use
18.15. GCC Countries Synthetic Biology Market Analysis
- 18.15.1. Value Proportion Analysis by Market Taxonomy
- 18.15.2. Value Analysis and Forecast by Market Taxonomy, 2019-2032
  - 18.15.2.1. By Application
  - 18.15.2.2. By Product Type
  - 18.15.2.3. By Technology
  - 18.15.2.4. By End-use
18.16. South Africa Synthetic Biology Market Analysis
- 18.16.1. Value Proportion Analysis by Market Taxonomy
- 18.16.2. Value Analysis and Forecast by Market Taxonomy, 2019-2032
  - 18.16.2.1. By Application
  - 18.16.2.2. By Product Type
  - 18.16.2.3. By Technology
  - 18.16.2.4. By End-use
18.17. Turkey Synthetic Biology Market Analysis
- 18.17.1. Value Proportion Analysis by Market Taxonomy
- 18.17.2. Value Analysis and Forecast by Market Taxonomy, 2019-2032
  - 18.17.2.1. By Application
  - 18.17.2.2. By Product Type
  - 18.17.2.3. By Technology
  - 18.17.2.4. By End-use
- 18.17.3. Competition Landscape and Player Concentration in the Country

19. Market Structure Analysis

19.1. Market Analysis by Tier of Companies
19.2. Market Concentration
19.3. Market Share Analysis of Top Players
19.4. Market Presence Analysis
- 19.4.1. By Regional footprint of Players
- 19.4.2. Product footprint by Players

20. Competition Analysis

20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
- 20.3.1. Bota Biosciences
  - 20.3.1.1. Overview
  - 20.3.1.2. Product Portfolio
  - 20.3.1.3. Sales Footprint
  - 20.3.1.4. Strategy Overview
- 20.3.2. Codexis, Inc.
  - 20.3.2.1. Overview
  - 20.3.2.2. Product Portfolio
  - 20.3.2.3. Sales Footprint
  - 20.3.2.4. Strategy Overview
- 20.3.3. Creative Biogene
  - 20.3.3.1. Overview
  - 20.3.3.2. Product Portfolio
  - 20.3.3.3. Sales Footprint
  - 20.3.3.4. Strategy Overview
- 20.3.4. Creative Enzymes
  - 20.3.4.1. Overview
  - 20.3.4.2. Product Portfolio
  - 20.3.4.3. Sales Footprint
  - 20.3.4.4. Strategy Overview
- 20.3.5. EnBiotix
  - 20.3.5.1. Overview
  - 20.3.5.2. Product Portfolio
  - 20.3.5.3. Sales Footprint
  - 20.3.5.4. Strategy Overview
- 20.3.6. Eurofins Scientific
  - 20.3.6.1. Overview
  - 20.3.6.2. Product Portfolio
  - 20.3.6.3. Sales Footprint
  - 20.3.6.4. Strategy Overview
- 20.3.7. Illumina
  - 20.3.7.1. Overview
  - 20.3.7.2. Product Portfolio
  - 20.3.7.3. Sales Footprint
  - 20.3.7.4. Strategy Overview
- 20.3.8. Merck (Sigma Aldrich)
  - 20.3.8.1. Overview
  - 20.3.8.2. Product Portfolio
  - 20.3.8.3. Sales Footprint
  - 20.3.8.4. Strategy Overview
- 20.3.9. New England Biolabs
  - 20.3.9.1. Overview
  - 20.3.9.2. Product Portfolio
  - 20.3.9.3. Sales Footprint
  - 20.3.9.4. Strategy Overview
- 20.3.10. Novozymes
  - 20.3.10.1. Overview
  - 20.3.10.2. Product Portfolio
  - 20.3.10.3. Sales Footprint
  - 20.3.10.4. Strategy Overview